Chapter 4. Radiopharmaceuticals Market: Product Business Analysis
4.1. Product Market Share, 2025 & 2040
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, Product, 2021 to 2040 (USD Billion)
4.4. Diagnostic Radiopharmaceuticals
4.4.1. Diagnostic Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.2. PET Radiopharmaceuticals
4.4.2.1. PET Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.2.2. F-18 FDG Radiopharmaceuticals
4.4.2.2.1. F-18 FDG Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.2.3. Ga-68-based Radiopharmaceuticals
4.4.2.3.1. Ga-68-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.2.4. F-18 PSMA-based Radiopharmaceuticals
4.4.2.4.1. F-18 PSMA-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.2.5. F-18 NaF Radiopharmaceuticals
4.4.2.5.1. F-18 NaF Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.2.6. F-18 Fluciclovine Radiopharmaceuticals
4.4.2.6.1. F-18 Fluciclovine Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.2.7. Rb-82-based Radiopharmaceuticals
4.4.2.7.1. Rb-82-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.2.8. N-13 Ammonia Radiopharmaceuticals
4.4.2.8.1. N-13 Ammonia Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.2.9. Others
4.4.2.9.1. Others Market, 2021 - 2040 (USD Billion)
4.4.3. SPECT Radiopharmaceuticals
4.4.3.1. SPECT Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.3.2. Tc-99m-based Radiopharmaceuticals
4.4.3.2.1. Tc-99m-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.3.3. I-123-based Radiopharmaceuticals
4.4.3.3.1. I-123-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.3.4. In-111-based Radiopharmaceuticals
4.4.3.4.1. In-111-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.3.5. Tl-201-based Radiopharmaceuticals
4.4.3.5.1. Tl-201-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.4.3.6. Others
4.4.3.6.1. Others Market, 2021 - 2040 (USD Billion)
4.5. Therapeutic Radiopharmaceuticals
4.5.1. Therapeutic Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.5.2. Beta Emitters
4.5.2.1. Beta Emitters Market, 2021 - 2040 (USD Billion)
4.5.2.2. Lu-177-based Radiopharmaceuticals
4.5.2.2.1. Lu-177-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.5.2.3. I-131-based Radiopharmaceuticals
4.5.2.3.1. I-131-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.5.2.4. Y-90-based Radiopharmaceuticals
4.5.2.4.1. Y-90-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.5.2.5. Others
4.5.2.5.1. Others Market, 2021 - 2040 (USD Billion)
4.5.3. Alpha Emitters
4.5.3.1. Alpha Emitters Market, 2021 - 2040 (USD Billion)
4.5.3.2. Ra-223-based Radiopharmaceuticals
4.5.3.2.1. Ra-223-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
4.5.3.3. Ac-225-based Radiopharmaceuticals
4.5.3.3.1. Ac-225-based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Chapter 5. Radiopharmaceuticals Market: Application Business Analysis
5.1. Application Market Share, 2025 & 2040
5.2. Application Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, Application, 2021 to 2040 (USD Billion)
5.4. Diagnostic Radiopharmaceuticals
5.4.1. Diagnostic Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
5.4.2. Oncology Imaging
5.4.2.1. Oncology Imaging Market, 2021 - 2040 (USD Billion)
5.4.3. Cardiac Imaging
5.4.3.1. Cardiac Imaging Market, 2021 - 2040 (USD Billion)
5.4.4. Neurology Imaging
5.4.4.1. Neurology Imaging Market, 2021 - 2040 (USD Billion)
5.4.5. Endocrine Imaging
5.4.5.1. Endocrine Imaging Market, 2021 - 2040 (USD Billion)
5.4.6. Renal Imaging
5.4.6.1. Renal Imaging Market, 2021 - 2040 (USD Billion)
5.4.7. Infection & Inflammation Imaging
5.4.7.1. Infection & Inflammation Imaging Market, 2021 - 2040 (USD Billion)
5.4.8. Others
5.4.8.1. Others Market, 2021 - 2040 (USD Billion)
5.5. Therapeutic Radiopharmaceuticals
5.5.1. Therapeutic Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
5.5.2. Prostate Cancer
5.5.2.1. Prostate Cancer Market, 2021 - 2040 (USD Billion)
5.5.3. Neuroendocrine Tumors
5.5.3.1. Neuroendocrine Tumors Market, 2021 - 2040 (USD Billion)
5.5.4. Thyroid Disorders
5.5.4.1. Thyroid Disorders Market, 2021 - 2040 (USD Billion)
5.5.5. Bone Metastases
5.5.5.1. Bone Metastases Market, 2021 - 2040 (USD Billion)
5.5.6. Liver Cancer
5.5.6.1. Liver Cancer Market, 2021 - 2040 (USD Billion)
5.5.7. Others
5.5.7.1. Others Market, 2021 - 2040 (USD Billion)
Chapter 6. Radiopharmaceuticals Market: End Use Business Analysis
6.1. End Use Market Share, 2025 & 2040
6.2. End Use Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, End Use, 2021 to 2040 (USD Billion)
6.4. Hospitals
6.4.1. Hospitals Market, 2021 - 2040 (USD Billion)
6.5. Diagnostic Imaging Centers
6.5.1. Diagnostic Imaging Centers Market, 2021 - 2040 (USD Billion)
6.6. Ambulatory Surgery Centers
6.6.1. Ambulatory Surgery Centers Market, 2021 - 2040 (USD Billion)
6.7. Specialty Clinics & Cath Labs
6.7.1. Specialty Clinics & Cath Labs Market, 2021 - 2040 (USD Billion)
6.8. Academic & Research Institutes
6.8.1. Academic & Research Institutes Market, 2021 - 2040 (USD Billion)
Chapter 7. Radiopharmaceuticals Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2025 & 2040
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2021 to 2040:
7.4. North America
7.4.1. North America Radiopharmaceuticals Market Estimates and Forecasts, Country, 2021 - 2040 (USD Billion)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Regulatory Framework
7.4.2.4. Reimbursement Framework
7.4.2.5. U.S. Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Regulatory Framework
7.4.3.4. Reimbursement Framework
7.4.3.5. Canada Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Regulatory Framework
7.4.4.4. Reimbursement Framework
7.4.4.5. Mexico Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.5. Europe
7.5.1. Europe Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement Framework
7.5.2.5. UK Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement Framework
7.5.3.5. Germany Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement Framework
7.5.4.5. France Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Regulatory Framework
7.5.5.4. Reimbursement Framework
7.5.5.5. Italy Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Target Disease Prevalence
7.5.6.3. Regulatory Framework
7.5.6.4. Reimbursement Framework
7.5.6.5. Spain Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Target Disease Prevalence
7.5.7.3. Regulatory Framework
7.5.7.4. Reimbursement Framework
7.5.7.5. Denmark Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Target Disease Prevalence
7.5.8.3. Regulatory Framework
7.5.8.4. Reimbursement Framework
7.5.8.5. Sweden Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Target Disease Prevalence
7.5.9.3. Regulatory Framework
7.5.9.4. Reimbursement Framework
7.5.9.5. Norway Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.6. Asia Pacific
7.6.1. Asia Pacific Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement Framework
7.6.2.5. Japan Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement Framework
7.6.3.5. China Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement Framework
7.6.4.5. India Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.6.5. Australia
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement Framework
7.6.5.5. Australia Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement Framework
7.6.6.5. South Korea Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Target Disease Prevalence
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement Framework
7.6.7.5. Thailand Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.7. Latin America
7.7.1. Latin America Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Target Disease Prevalence
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement Framework
7.7.2.5. Brazil Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Target Disease Prevalence
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement Framework
7.7.3.5. Argentina Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.8. Middle East and Africa
7.8.1. Middle East and Africa Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Target Disease Prevalence
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement Framework
7.8.2.5. South Africa Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Target Disease Prevalence
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement Framework
7.8.3.5. Saudi Arabia Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Target Disease Prevalence
7.8.4.3. Regulatory Framework
7.8.4.4. Reimbursement Framework
7.8.4.5. UAE Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Target Disease Prevalence
7.8.5.3. Regulatory Framework
7.8.5.4. Reimbursement Framework
7.8.5.5. Kuwait Radiopharmaceuticals Market Estimates and Forecasts, 2021 - 2040 (USD Billion)
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Radiopharmaceuticals Market, Region, 2021 - 2040 (USD Billion)
Table 4 Global Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 5 Global Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 6 Global Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 7 North America Radiopharmaceuticals Market, Country, 2021 - 2040 (USD Billion)
Table 8 North America Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 9 North America Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 10 North America Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 11 U.S. Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 12 U.S. Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 13 U.S. Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 14 Canada Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 15 Canada Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 16 Canada Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 17 Mexico Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 18 Mexico Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 19 Mexico Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 20 Europe Radiopharmaceuticals Market, Country, 2021 - 2040 (USD Billion)
Table 21 Europe Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 22 Europe Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 23 Europe Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 24 UK Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 25 UK Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 26 UK Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 27 Germany Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 28 Germany Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 29 Germany Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 30 France Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 31 France Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 32 France Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 33 Italy Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 34 Italy Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 35 Italy Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 36 Spain Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 37 Spain Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 38 Spain Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 39 Norway Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 40 Norway Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 41 Norway Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 42 Denmark Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 43 Denmark Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 44 Denmark Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 45 Sweden Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 46 Sweden Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 47 Sweden Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 48 Asia Pacific Radiopharmaceuticals Market, Country, 2021 - 2040 (USD Billion)
Table 49 Asia Pacific Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 50 Asia Pacific Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 51 Asia Pacific Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 52 Japan Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 53 Japan Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 54 Japan Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 55 China Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 56 China Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 57 China Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 58 India Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 59 India Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 60 India Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 61 Australia Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 62 Australia Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 63 Australia Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 64 South Korea Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 65 South Korea Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 66 South Korea Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 67 Thailand Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 68 Thailand Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 69 Thailand Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 70 Latin America Radiopharmaceuticals Market, Country, 2021 - 2040 (USD Billion)
Table 71 Latin America Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 72 Latin America Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 73 Latin America Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 74 Brazil Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 75 Brazil Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 76 Brazil Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 77 Argentina Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 78 Argentina Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 79 Argentina Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 80 Middle East & Africa Radiopharmaceuticals Market, Country, 2021 - 2040 (USD Billion)
Table 81 Middle East & Africa Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 82 Middle East & Africa Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 83 Middle East & Africa Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 84 South Africa Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 85 South Africa Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 86 South Africa Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 87 Saudi Arabia Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 88 Saudi Arabia Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 89 Saudi Arabia Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 90 UAE Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 91 UAE Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 92 UAE Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
Table 93 Kuwait Radiopharmaceuticals Market, Product, 2021 - 2040 (USD Billion)
Table 94 Kuwait Radiopharmaceuticals Market, Application, 2021 - 2040 (USD Billion)
Table 95 Kuwait Radiopharmaceuticals Market, End Use, 2021 - 2040 (USD Billion)
List of Figures
Figure 1 Radiopharmaceuticals Market Segmentation
Figure 2 Market Research Process
Figure 3 Data Triangulation Techniques
Figure 4 Primary Research Pattern
Figure 5 Market Research Approaches
Figure 6 Value-Chain-Based Sizing & Forecasting
Figure 7 Market Formulation & Validation
Figure 8 Market Snapshot
Figure 9 Competitive Landscape
Figure 10 Radiopharmaceuticals Market Dynamics
Figure 11 Radiopharmaceuticals Market: Porter’s Five Forces Analysis
Figure 12 Radiopharmaceuticals Market: PESTLE Analysis
Figure 13 Product Market, 2021 - 2040 (USD Billion)
Figure 14 Diagnostic Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 15 PET Radiopharmaceuticals, 2021 - 2040 (USD Billion)
Figure 16 F-18 FDG Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 17 Ga-68-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 18 F-18 PSMA-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 19 F-18 NaF Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 20 F-18 Fluciclovine Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 21 Rb-82-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 22 N-13 Ammonia Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 23 Others Market, 2021 - 2040 (USD Billion)
Figure 24 SPECT Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 25 Tc-99m-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 26 I-123-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 27 In-111-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 28 Tl-201-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 29 Others Market, 2021 - 2040 (USD Billion)
Figure 30 Therapeutic Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 31 Beta Emitters Market, 2021 - 2040 (USD Billion)
Figure 32 Lu-177-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 33 I-131-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 34 Y-90-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 35 Others Market, 2021 - 2040 (USD Billion)
Figure 36 Alpha Emitters Market, 2021 - 2040 (USD Billion)
Figure 37 Ra-223-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 38 Ac-225-Based Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 39 Application Market, 2021 - 2040 (USD Billion)
Figure 40 Diagnostic Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 41 Oncology Imaging Market, 2021 - 2040 (USD Billion)
Figure 42 Cardiac Imaging Market, 2021 - 2040 (USD Billion)
Figure 43 Neurology Imaging Market, 2021 - 2040 (USD Billion)
Figure 44 Endocrine Imaging Market, 2021 - 2040 (USD Billion)
Figure 45 Renal Imaging Market, 2021 - 2040 (USD Billion)
Figure 46 Infection & Inflammation Imaging Market, 2021 - 2040 (USD Billion)
Figure 47 Others Market, 2021 - 2040 (USD Billion)
Figure 48 Therapeutic Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 49 Prostate Cancer Market, 2021 - 2040 (USD Billion)
Figure 50 Neuroendocrine Tumors Market, 2021 - 2040 (USD Billion)
Figure 51 Thyroid Disorders Market, 2021 - 2040 (USD Billion)
Figure 52 Bone Metastases Market, 2021 - 2040 (USD Billion)
Figure 53 Liver Cancer Market, 2021 - 2040 (USD Billion)
Figure 54 Others Market, 2021 - 2040 (USD Billion)
Figure 55 End Use Market, 2021 - 2040 (USD Billion)
Figure 56 Hospitals Market, 2021 - 2040 (USD Billion)
Figure 57 Diagnostic Imaging Centers Market, 2021 - 2040 (USD Billion)
Figure 58 Ambulatory Surgery Centers Market, 2021 - 2040 (USD Billion)
Figure 59 Specialty Clinics & Cath Labs Market, 2021 - 2040 (USD Billion)
Figure 60 Academic & Research Institutes Market, 2021 - 2040 (USD Billion)
Figure 61 Radiopharmaceuticals Market Revenue, Region
Figure 62 Regional Marketplace: Key Takeaways
Figure 63 North America Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 64 U.S. Country Dynamics
Figure 65 U.S. Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 66 Canada Country Dynamics
Figure 67 Canada Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 68 Mexico Country Dynamics
Figure 69 Mexico Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 70 Europe Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 71 UK Country Dynamics
Figure 72 UK Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 73 Germany Country Dynamics
Figure 74 Germany Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 75 France Country Dynamics
Figure 76 France Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 77 Italy Country Dynamics
Figure 78 Italy Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 79 Spain Country Dynamics
Figure 80 Spain Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 81 Norway Country Dynamics
Figure 82 Norway Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 83 Sweden Country Dynamics
Figure 84 Sweden Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 85 Denmark Country Dynamics
Figure 86 Denmark Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 87 Asia Pacific Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 88 Japan Country Dynamics
Figure 89 Japan Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 90 China Country Dynamics
Figure 91 China Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 92 India Country Dynamics
Figure 93 India Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 94 Australia Country Dynamics
Figure 95 Australia Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 96 South Korea Country Dynamics
Figure 97 South Korea Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 98 Thailand Country Dynamics
Figure 99 Thailand Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 100 Latin America Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 101 Brazil Country Dynamics
Figure 102 Brazil Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 103 Argentina Country Dynamics
Figure 104 Argentina Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 105 MEA Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 106 South Africa Country Dynamics
Figure 107 South Africa Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 108 Saudi Arabia Country Dynamics
Figure 109 Saudi Arabia Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 110 UAE Country Dynamics
Figure 111 UAE Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 112 Kuwait Country Dynamics
Figure 113 Kuwait Radiopharmaceuticals Market, 2021 - 2040 (USD Billion)
Figure 114 Company Categorization
Figure 115 Company Market Position Analysis
Figure 116 Strategic Framework